Cargando…
Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
L1 is a dizinc subclass B3 metallo-β-lactamase (MBL) that hydrolyzes most β-lactam antibiotics and is a key resistance determinant in the Gram-negative pathogen Stenotrophomonas maltophilia, an important cause of nosocomial infections in immunocompromised patients. L1 is not usefully inhibited by MB...
Autores principales: | Hinchliffe, Philip, Calvopiña, Karina, Rabe, Patrick, Mojica, Maria F., Schofield, Christopher J., Dmitrienko, Gary I., Bonomo, Robert A., Vila, Alejandro J., Spencer, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148155/ https://www.ncbi.nlm.nih.gov/pubmed/36924941 http://dx.doi.org/10.1016/j.jbc.2023.104606 |
Ejemplares similares
-
Cyclobutanone Mimics of Intermediates in Metallo‐β‐Lactamase Catalysis
por: Abboud, Martine I., et al.
Publicado: (2018) -
Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors
por: Reddy, Nakita, et al.
Publicado: (2023) -
Profiling interactions of vaborbactam with metallo-β-lactamases
por: Langley, Gareth W., et al.
Publicado: (2019) -
Structural Basis of Metallo-β-lactamase Inhibition
by N-Sulfamoylpyrrole-2-carboxylates
por: Farley, Alistair J. M., et al.
Publicado: (2021) -
In Vitro and
In Vivo Development of a β-Lactam-Metallo-β-Lactamase
Inhibitor: Targeting Carbapenem-Resistant Enterobacterales
por: Peters, Byron K., et al.
Publicado: (2023)